{"id":4628,"date":"2025-03-31T18:12:14","date_gmt":"2025-03-31T18:12:14","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/potassium-chloride-txt\/"},"modified":"2025-03-31T18:12:14","modified_gmt":"2025-03-31T18:12:14","slug":"potassium-chloride-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/potassium-chloride-txt\/","title":{"rendered":"potassium chloride.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3><br \/>\nHypokalaemia<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>2\u20134 g (25\u201350 mmol) daily<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :74.6<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :N\/A<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : N\/A<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :N\/A<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :N\/A<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4><LI> 20 to 50  &amp;nbsp &amp;nbsp : According to response<LI> 10 to 20  &amp;nbsp &amp;nbsp : According to response<LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : According to response<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Dialysed. Dose according to response<\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Dialysed. Dose according to response<LI>HDF\/high flux  &amp;nbsp :Dialysed. Dose according to response<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Dialysed. Dose according to response<H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugsACE inhibitors and angiotensin- II antagonists: increased risk of hyperkalaemia\n<li>Ciclosporin: increased risk of  hyperkalaemiaPotassium-sparing diuretics: increased risk  of hyperkalaemia\n<li>  Tacrolimus: increased risk of  hyperkalaemia<H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>\u2013<H4>  Route  <\/H4>Oral, IV  <H4>  Rate of Administration  <\/H4>Infusion up to 20 mmol potassium per  hour except in extreme hypokalaemic emergency where some units give up to 40 mmol\/hour with cardiac monitoring<H4>Comments<\/H4>Give IV solution well diluted (not  exceeding 40 mmol\/500 mL) for peripheral administrationMix IV solutions thoroughly to avoid  layering effectSome units give more concentrated  solution centrally: 100\u2013200 mmol\/100 mL sodium chloride 0.9% or glucose 5%, but at a rate not more than 20 mmol\/hourCardiac monitoring mandatory <H4>  OTHER INFORMATION  <\/H4>Potassium chloride injection MUST NOT  be injected undilutedMonitor serum potassium levels Sando K: 12 mmol potassium per tablet Slow K: 8 mmol potassium per tablet Kay-Cee-L Syrup: 1 mmol potassium per  mLPotassium chloride strong 15% injection:  20 mmol potassium \/10 mL<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Hypokalaemia DOSE IN NORMAL RENAL FUNCTION 2\u20134 g<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4628","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4628","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4628"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4628\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}